Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability remains years away.

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 5.44% at $49.93. This move lagged the S&P 500's daily loss of 0.08%. On the other hand, the Dow registered a loss of 0.61%, and the ...

Key opportunities in Saudi Arabia's synthetic biology market include leveraging government investments and biotechnology advancements driven by Vision 2030. The focus is on reducing oil dependence by ...

Cathie Wood’s ARK Invest added to several beaten-down technology and biotech names while trimming positions elsewhere. The investment manager made a notable purchase in gene-editing company CRISPR ...

Tropic will establish a mother plantation to support commercial deployment of bananas resistant to fusarium wilt (TR4) from 2027.

Researchers have used mouse models to study how cocaine addiction alters the brain, illuminating why relapse is common as ...

One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand treatment to others.

In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...

CRISPR Therapeutics (NASDAQ: CRSP) is a company that can potentially help revolutionize healthcare. Its gene-editing therapies can be game changers for patients living with illnesses and conditions ...

Researchers are applying CRISPR-Cas9 as a stoichiometric binding tool to improve NGS library normalization. The ...